Bayer has agreed to divest its Liberty herbicide and Liberty Link-branded seeds businesses across the globe to win antitrust approval for its planned merger with Monsanto, it said on Monday.
The conditions were imposed by South Africa’s Competition Commission on Sunday and agreed to by Bayer.
While South Africa is a relatively small market for the two global agricultural supplies giants, the move marks the first time that Bayer has acknowledged it has to sell the two related Liberty brands, which compete with Monsanto’s Roundup weed killer and Roundup Ready seeds.
The planned divestitures are widely expected to be also imposed by watchdogs in larger jurisdictions, such as the United States and the European Union, where antitrust procedures are still ongoing.
In March, the German drug and crop chemicals maker, together with Monsanto, began the process of selling assets worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI